(Q53904712)

22 May 2018

title

Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis. (English)

1 reference

22 May 2018

0 references

0 references

1 reference

multiple drug resistance

1 reference

1 reference

Mario C Raviglione

3

0 references

author name string

Rajesh Gupta

series ordinal

1

1 reference

22 May 2018

Alexander Irwin

series ordinal

2

1 reference

22 May 2018

Jim Yong Kim

series ordinal

4

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 January 2004

1 reference

22 May 2018

published in

The Lancet

1 reference

22 May 2018

volume

363

1 reference

22 May 2018

issue

9405

1 reference

22 May 2018

page(s)

320-324

1 reference

22 May 2018

Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

Multidrug-resistant tuberculosis in patients without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

PUBLIC HEALTH: Responding to Market Failures in Tuberculosis Control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

Drug-resistant tuberculosis: desperate measures?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

Increasing transparency in partnerships for health--introducing the Green Light Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

Antiretroviral treatment in resource-poor settings: clinical research priorities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

Out-licensing: a practical approach for improvement of access to medicines in poor countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

Tackling HIV in resource poor countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

Community-based approaches to HIV treatment in resource-poor settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

Global health improvement and WHO: shaping the future

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915394-9

7 January 2021

10.1016/S0140-6736(03)15394-9

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

14751708

1 reference

22 May 2018